IHM
Iguana Healthcare Management Portfolio holdings
AUM
$133M
This Quarter Return
+8.94%
1 Year Return
+45.66%
3 Year Return
+127.07%
5 Year Return
–
10 Year Return
–
AUM
$160M
AUM Growth
+$160M
(-3.8%)
Cap. Flow
-$13.6M
Cap. Flow
% of AUM
-8.54%
Top 10 Holdings %
Top 10 Hldgs %
50.16%
Holding
74
New
13
Increased
12
Reduced
21
Closed
14
Top Buys
| 1 |
Zimmer Biomet
ZBH
|
$5.03M |
| 2 |
Gilead Sciences
GILD
|
$4.52M |
| 3 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
$3.11M |
| 4 |
DexCom
DXCM
|
$2.6M |
| 5 |
AbbVie
ABBV
|
$2.31M |
Top Sells
| 1 |
HCA Healthcare
HCA
|
$4.51M |
| 2 |
Puma Biotechnology
PBYI
|
$4.18M |
| 3 |
Merck
MRK
|
$4M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$3.91M |
| 5 |
STJ
St Jude Medical
STJ
|
$3.64M |
Sector Composition
| 1 | Healthcare | 83.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Biogen
BIIB
$19.4B
| $14.1M | 7.51% | 42,500 +4,500 | +12% | +$1.49M |
|
|
2
Gilead Sciences
GILD
$140B
| $12.5M | 6.68% | 117,500 +42,500 | +57% | +$4.52M |
|
3
Amgen
AMGN
$155B
| $11.4M | 6.12% | 81,500 -1,000 | -1% | -$140K |
|
4
Medtronic
MDT
$119B
| $8.52M | 4.55% | 137,500 -15,000 | -10% | -$929K |
|
|
5
AbbVie
ABBV
$372B
| $7.22M | 3.86% | 125,000 +40,000 | +47% | +$2.31M |
|
|
CELG
6
DELISTED
Celgene Corp
CELG
| $7.11M | 3.8% | 75,000 -30,000 | -29% | -$2.84M |
|
7
Supernus Pharmaceuticals
SUPN
$2.53B
| $5.22M | 2.79% | 600,000 +225,000 | +60% | +$1.96M |
|
|
8
Zimmer Biomet
ZBH
$21B
| $5.03M | 2.69% | +50,000 | New | +$5.03M |
|
|
9
Merck
MRK
$210B
| $4.74M | 2.53% | 80,000 -67,500 | -46% | -$4M |
|
|
TRNX
10
DELISTED
TORNIER N V SHARES (NLD)
TRNX
| $4.18M | 2.23% | 175,000 +50,000 | +40% | +$1.2M |
|
|
GWPH
11
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $4.04M | 2.16% | 50,000 +7,500 | +18% | +$606K |
|
|
AERI
12
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $3.93M | 2.1% | 190,000 +44,300 | +30% | +$917K |
|
13
Viatris
VTRS
$12.3B
| $3.64M | 1.94% | 80,000 -25,000 | -24% | -$1.14M |
|
14
Ionis Pharmaceuticals
IONS
$6.79B
| $3.3M | 1.76% | 85,000 -50,000 | -37% | -$1.94M |
|
15
Ultragenyx Pharmaceutical
RARE
$2.89B
| $3.26M | 1.74% | 57,500 +15,700 | +38% | +$889K |
|
|
RCPT
16
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $3.11M | 1.66% | +50,000 | New | +$3.11M |
|
17
Esperion Therapeutics
ESPR
$448M
| $3.06M | 1.63% | 125,000 | – | – |
|
|
SPNC
18
DELISTED
Spectranetics Corp
SPNC
| $3.06M | 1.63% | 115,000 -10,000 | -8% | -$266K |
|
|
ETRM
19
DELISTED
EnteroMedics Inc.
ETRM
| $2.88M | 1.54% | 2,344,000 +1,744,000 | +291% | +$2.15M |
|
|
HZNP
20
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $2.7M | 1.44% | 220,000 -35,000 | -14% | -$430K |
|
|
AVNR
21
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
| $2.68M | 1.43% | 225,000 -25,000 | -10% | -$298K |
|
|
22
DexCom
DXCM
$29.5B
| $2.6M | 1.39% | +65,000 | New | +$2.6M |
|
|
WMGI
23
DELISTED
Wright Medical Group Inc
WMGI
| $2.58M | 1.38% | 85,000 | – | – |
|
24
Alkermes
ALKS
$4.78B
| $2.57M | 1.37% | 60,000 -25,000 | -29% | -$1.07M |
|
25
Tenet Healthcare
THC
$16.3B
| $2.52M | 1.35% | 42,500 -42,500 | -50% | -$2.52M |
|